欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

您的位置 : 首页  /  PI3K/Akt/mTOR  /  mTOR  /  Ridaforolimus

CAS No.: 572924-54-0

Ridaforolimus Catalog No. CSN13765

Synonyms: MK-8669;Deforolimus;AP23573

Treatment of HT-1080 cells with Deforolimus induces a dose-dependent inhibition of phosphorylation of both S6 and 4E-BP1, with IC50 of 0.2 nM and 5.6 nM, respectively, and leads to a decrease in cell size, an increase in the proportion of cells in the G1 phase of the cell cycle, and inhibition of glucose uptake.

规格 价格 促销价格 库存 数量
纯度 & 质量文件 批次:

靶点选择性

生物活性

  • 靶点mTOR

    IC50:0.2nM
  • 描述
  • 临床研究
  • NCT号适应症或疾病临床期招募状态预计完成时间地点
    NCT00667615Hodgkin's Disease ... more >> Lymphoma Collapse <<Phase 1 Phase 2Completed-United States, New Jersey ... more >> Memorial Sloan Kettering Cancer Center @ BaskingRidge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Weill Cornell Medical Center New York, New York, United States Memorial Sloan Kettering Cancer Center @ Phelps Sleepy Hollow, New York, United States, 10591 Collapse <<
    NCT01995500Coronary Artery StenosisPhase 2Active, not recruitingSeptember 2020Israel ... more >> Hadassah Hebrew University Medical Center Jerusalem, Israel, 91129 Collapse <<
    NCT01243762Neoplasms MalignantPhase 1Terminated(The study was termi... more >>nated for business reasons and not due to any safety or efficacy concerns related to dalotuzumab.) Collapse <<--
  • 更多

实验方案

技术信息

CAS号 572924-54-0 储存条件
分子式 C53H84NO14P 运输 蓝冰
分子量 990.21 别名 MK-8669;Deforolimus;AP23573

大规格询价

号为必填项

姓名: 邮箱: 手机号:
留言:
   提交
联系
我们